Cargando…
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
BACKGROUND: Levetiracetam is a broad spectrum antiepileptic drug (AED) with proven efficacy when used as adjunctive therapy against myoclonic seizures. We report two patients suffering from epilepsy with myoclonic-astatic epilepsy (MAE) who experienced a paradoxical worsening of seizures after initi...
Autores principales: | Makke, Yamane, Hmaimess, Ghassan, Nasreddine, Wassim, Fawaz, Ahmad, Beydoun, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329645/ https://www.ncbi.nlm.nih.gov/pubmed/25884503 http://dx.doi.org/10.1186/s12887-015-0330-y |
Ejemplares similares
-
New SMARCA2 mutation in a patient with Nicolaides–Baraitser syndrome and myoclonic astatic epilepsy
por: Tang, S., et al.
Publicado: (2016) -
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
por: Auvin, Stéphane
Publicado: (2007) -
Levetiracetam for the treatment of myoclonic neurotoxicity induced by amiodarone
por: Celli, Diego, et al.
Publicado: (2020) -
Intractable myoclonic seizures in an allogeneic stem cell transplant recipient: A rare case of myoclonic epilepsy
por: Robuccio, Anna, et al.
Publicado: (2015) -
A Case of Dissociative Seizures Presented like Myoclonic Epilepsy
por: REDDY, Balaswamy, et al.
Publicado: (2018)